Transplant-associated arteriosclerosis (TAA) is the major cause of death in recipients who survive more than one year after cardiac transplantation. TAA is characterized by infiltration of inflammatory cells followed by the formation of a diffuse, concentric neointima in which smooth muscle cells and lipid-laden macrophages accumulate. Cells of the immune system-particularly the macrophage-play a key role in TAA. Through uptake of oxidized lipids, elaboration of inflammatory cytokines, and release of proteolytic enzymes, activated macrophages are critical to TAA. The long-term objectives are to identify mechanisms regulating these processes. The pleiotropic growth factor, TGF-01, is an important regulator of cellular growth, differentiation, and immune modulation. Efforts to elucidate mechanisms by which TGF-beta1 mediates its functions have identified a number of effector proteins termed Smads. Although nine Smads have been identified, their role in macrophage biology has not been assessed. We found that a single member of the Smad family. Smad3-is critical for inhibiting markers of macrophage activation. This proposal aims to investigate the role of Smad3 in regulating activated macrophages and its role in the pathogenesis of TAA. Our data suggest that a novel mechanism is regulating Smad3's inhibitory function likely involving binding to an essential co-factor in macrophages. Thus, we propose to identify and characterize interaction partners for Smad3 in macrophages and assess how such factor(s) may affect Smad3's regulation on macrophage activation. To assess the effect of Smad3 on a broad range of macrophage effector functions, we will employ adenoviral strategies to overexpress both Smad3 and a dominant negative Smad3 in macrophages. Finally, to evaluate the in vivo role of Smad3, we will determine the contribution of Smad3 in the development of transplant arteriopathy using a mouse model of cardiac allograft transplantation in Smad3-/- recipient mice. Insight into the mechanism governing SmadYs role in inflammation may provide potential, therapeutic targets applicable to a number of inflammatory diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL067755-02
Application #
6527841
Study Section
Special Emphasis Panel (ZHL1-CSR-M (M1))
Program Officer
Commarato, Michael
Project Start
2001-09-04
Project End
2006-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
2
Fiscal Year
2002
Total Cost
$133,920
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Feinberg, Mark W; Wara, Akm Khyrul; Cao, Zhuoxiao et al. (2007) The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J 26:4138-48
Das, Hiranmoy; Kumar, Ajay; Lin, Zhiyong et al. (2006) Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc Natl Acad Sci U S A 103:6653-8
Feinberg, Mark W; Cao, Zhuoxiao; Wara, Akm Khyrul et al. (2005) Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J Biol Chem 280:38247-58
Feinberg, M W; Jain, M K (2005) Role of transforming growth factor-beta1/Smads in regulating vascular inflammation and atherogenesis. Panminerva Med 47:169-86
Shi, Can; Zhang, Xiaobin; Chen, Zhiping et al. (2004) Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J Clin Invest 114:408-18
Feinberg, Mark W; Watanabe, Masafumi; Lebedeva, Maria A et al. (2004) Transforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3. J Biol Chem 279:16388-93
Feinberg, Mark W; Lin, Zhiyong; Fisch, Sudeshna et al. (2004) An emerging role for Kruppel-like factors in vascular biology. Trends Cardiovasc Med 14:241-6
Feinberg, Mark W; Shimizu, Koichi; Lebedeva, Maria et al. (2004) Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. Circ Res 94:601-8
Gray, Susan; Feinberg, Mark W; Hull, Sarah et al. (2002) The Kruppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4. J Biol Chem 277:34322-8